anti lamp2a antibody (Santa Cruz Biotechnology)
Structured Review

Anti Lamp2a Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 960 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+lamp2a+antibody/LAMP-2+Antibody/pmc12999990-336-75-77
Average 96 stars, based on 960 article reviews
Images
1) Product Images from "Lysosome-targeting live attenuated influenza vaccines elicit robust and broad immunity in mice"
Article Title: Lysosome-targeting live attenuated influenza vaccines elicit robust and broad immunity in mice
Journal: Nature Communications
doi: 10.1038/s41467-026-69920-0
Figure Legend Snippet: a LTM-dependent degradation of viral NS1 protein. Western blot analysis shows reduced NS1 protein levels in cells expressing NS1-N LTM compared with the N LTM mutant , while NS1 mRNA levels remain comparable ( n = 3). b Lysosome dependence of LTM-mediated NS1 degradation. NS1-N LTM protein degradation is blocked by lysosomal inhibitors but not by proteasome or autophagy inhibition. HEK293T cells expressing either NS1-N LTM (left) or NS1-N LTM mutant (right) protein were cultured with or without the proteasome inhibitor MG-132 (10 µM), the autophagy inhibitor 3-methyladenine (3-MA; 10 mM), bafilomycin A1 (Baf A1; 0.4 µM), or chloroquine (CQ; 50 µM) for 6 h. The viral NS1 protein was detected by Western blotting ( n = 3). c Co-immunoprecipitation demonstrating interaction of HSC70 with NS1-N LTM but not with the NS1 LTM mutant ( n = 3). d Dependence of LTM-mediated NS1 degradation on LAMP2A. Conventional HEK293T cells and LAMP2A-KO HEK293T cells were transfected with constructs expressing NS1-N LTM (left) or NS1-N LTM mutant (right) protein and collected 24 h post-transfection. Viral NS1 protein was detected by Western blotting ( n = 3). Immunofluorescence analysis showing colocalization of NS1-N LTM with HSC70 ( e ) and LAMP2A ( f ), but not of the NS1-N LTM mutant . Green, NS1; red, HSC70 or LAMP2A; blue, nuclei; yellow, colocalization sites; scale bar, 5 µm. Representative images of at least three independent experiments are shown. LAMP2A-dependent degradation of NS1-N LTM during viral infection in conventional and LAMP2A-KO HEK293T ( g ) and A549 ( h ) cells. Replication competence of NS1-N LTM and NS1-N LTM mutant viruses in conventional and LAMP2A-KO HEK293T ( i ) and A549 ( j ) cells. Immunofluorescence staining of influenza viral M1 protein at 48 h after infection (MOI = 0.01) showing the replication competence of NS1-N LTM or NS1-N LTM mutant virus in conventional and LAMP2A-KO cells. Green, M1; blue, nuclei; scale bar, 100 µm. Viral titers in culture supernatants were quantified by immunofluorescence focus-forming unit (FFU) assay ( n = 3). Data are means ± s.d; n = 3 biologically independent experiments; unpaired two-tailed t -test for ( i ) and ( j ); *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Expressing, Mutagenesis, Inhibition, Cell Culture, Immunoprecipitation, Transfection, Construct, Immunofluorescence, Infection, Staining, Virus, Two Tailed Test
Figure Legend Snippet: a Schematic illustration depicting the design and generation of LYTAR 2.0 influenza viruses. LYTAR 2.0 viruses are attenuated in conventional cells through LTM-mediated viral protein degradation by the CMA system but can replicate efficiently in LAMP2A-knockout (KO) cells. VP stands for viral protein. b Western blots showing the dependence of LTM-mediated viral protein degradation on the lysosome. HEK293T cells expressing the indicated viral proteins were cultured in the presence or absence of Baf A1 (0.4 µM) for 6 h. The viral proteins were detected by Western blotting ( n = 3). c Western blots showing the LAMP2A dependency of LTM-mediated viral protein degradation. Conventional HEK293T cells and LAMP2A-KO HEK293T cells were transfected with constructs expressing the indicated viral proteins and collected 24 h post-transfection for viral protein detection by Western blotting ( n = 3). d Western blots showing the LAMP2A dependency of LTM-mediated viral protein degradation in HEK293T cells. Conventional HEK293T cells and LAMP2A-KO HEK293T cells were infected with the indicated LYTAR 2.0 viruses and collected 48 h post-infection for detection of viral proteins by Western blotting ( n = 3). e Western blots showing the LAMP2A dependence of LTM-mediated viral protein degradation in A549 cells. Conventional A549 cells and LAMP2A-KO A549 cells were infected with the indicated LYTAR 2.0 viruses and collected 48 h post-infection for detection of viral proteins by Western blotting ( n = 3). Source data are provided as a Source Data file.
Techniques Used: Knock-Out, Western Blot, Expressing, Cell Culture, Transfection, Construct, Infection
Figure Legend Snippet: a Multi-cycle replication kinetics of the indicated viruses in conventional and LAMP2A-KO MDCK cells. Data are presented as means ± s.d ( n = 3). b triLTM-dependent degradation of viral proteins. Western blot analysis shows reduced levels of triLTM-tagged viral proteins compared with mutated triLTM-tagged controls, while corresponding mRNA levels remain comparable ( n = 3). c Lysosome dependence of triLTM-mediated viral protein degradation. HEK293T cells expressing triLTM-tagged or mutated triLTM-tagged viral proteins were cultured in the presence or absence of Baf A1 (0.4 µM) for 6 h and collected for detection of indicated viral proteins by Western blotting ( n = 3). d Co-immunoprecipitation demonstrating interaction of HSC70 with triLTM-tagged viral proteins but not with mutated triLTM-tagged viral proteins ( n = 3). LAMP2A-dependent degradation of triLTM-tagged viral proteins during viral infection in conventional and LAMP2A-KO HEK293T ( e ) and A549 ( f ) cells ( n = 3). Conventional cells and LAMP2A-KO cells were infected with LYTAR 2.0 dual triLTMs or LYTAR 2.0 dual triLTMs mutant virus and collected at 48 h after infection for detection of indicated proteins by Western blotting ( n = 3). Replication competence of LYTAR 2.0 dual triLTMs and LYTAR 2.0 dual triLTMs mutant viruses in conventional and LAMP2A-KO HEK293T ( g ) and A549 ( h ) cells. Immunofluorescence staining of influenza viral M1 protein at 48 h after infection (MOI = 0.01) showing the replication competence of LYTAR 2.0 dual triLTMs and LYTAR 2.0 dual triLTMs mutant virus in conventional and LAMP2A-KO HEK293T cells. Green, M1; blue, nuclei; scale bar, 100 µm. Viral titers in culture supernatants were quantified by immunofluorescence focus-forming unit (FFU) assay ( n = 3). Data are means ± s.d; n = 3 biologically independent experiments; unpaired two-tailed t -test for ( g ) and ( h ); *** P < 0.001. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Expressing, Cell Culture, Immunoprecipitation, Infection, Mutagenesis, Virus, Immunofluorescence, Staining, Two Tailed Test
Related Articles
Incubation:Article Title: Lysosome-targeting live attenuated influenza vaccines elicit robust and broad immunity in mice Article Snippet: .. After another 6 h of culture, the cells were washed with PBS, fixed with 4% paraformaldehyde (PFA) for 20 min at room temperature, washed with PBS, permeabilized with PBS containing 0.1% Triton X-100 for 5 min, blocked with PBS containing with 0.1% Triton X-100 and 10% goat serum for 1 h at room temperature, and incubated with anti-Flag antibody (MBL, Cat# PM020; 1:1000 dilution) and anti-HSC70 antibody (Santa Cruz Biotechnology, Cat# sc-7298; 1:300 dilution) or Article Title: HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition. Article Snippet: Department of Dermatovenereology, The Seventh Affiliated Hospital, Sun Yat‐sen University, Shenzhen, Guangdong, P. R. China Department of Pathology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, P. R. China Department of Dermatovenereology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China Research Center, The Seventh Affiliated Hospital, Sun Yat‐sen University, Shenzhen, Guangdong, P. R. China Department of Gynaecology and Obstetrics, The Seventh Affiliated Hospital, Sun Yat‐sen University, Shenzhen, Guangdong, P. R. China Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China |